Archer-Daniels-Midland Company Common Stock (NYSE: ADM)
The Complaint alleges that throughout the Class Period, Defendants made false and/or misleading statements, as well as failed to disclose material facts, about the performance and prospects of ADM’s Nutrition segment and its accounting practices. Specifically, the Complaint alleges Defendants made positive statements about the Nutrition segment as a future profit-driver for the Company, with the ability to capitalize on healthier eating trends and rising consumer demand for natural ingredients and flavoring, and that Defendants created the impression that the Nutrition segment’s growth would provide more diversification and earnings stability for ADM. However, the Complaint alleges that the Nutrition segment’s ostensibly impressive growth was inaccurate and subject to improper accounting practices, and Defendants also downplayed the segment’s eventual decline in 2023. The Complaint claims that Defendants' actions caused the price of ADM common stock to trade at artificially inflated levels during the Class Period.